Cardiovascular Prosthetic Devices Market Projected to Gain Significant Value through 2032
The global cardiovascular prosthetic devices market is estimated to be worth US$ 5.1 billion in 2021 and to grow at an 8.1% CAGR to US$ 11.9 billion by 2032. The goal of cardiovascular prosthetic device development is to replace injured heart tissues. These devices are designed to perform similarly to regular cardiovascular systems. Cardiovascular prostheses have increased cardiac surgeons' ability to repair heart blockages. The two most frequent prosthesis are pacemakers and heart valves. The growing prevalence of atrial septal defect (ASD) and valvular illness, rising rates of cardiovascular disease, and an ageing population are driving the demand for cardiovascular prosthetic devices. New technological breakthroughs and increasing adoption rates of these devices are expected to push the market throughout the forecast period. Furthermore, an increase in the elderly population, a preference for minimally invasive procedures, technological advancements resulting in the devel...